Phase II trial of CPX-351 (cytarabine:daunorubicin) liposome injection in patients with acute myeloid leukemia >60 years of age who have not been treated with intensive chemotherapy.

Ellen K. Ritchie, Gail J. Roboz, Pinkal Desai et al.|Journal of Clinical Oncology|2019

Cited by 0